MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview at the Lehman Brothers Global Healthcare Conference on March 19 in Miami. The GTx presentation, which will highlight the company’s clinical development programs and the recently announced results of the ACAPODENE® 80 mg Phase III ADT clinical trial, will begin at 2:00 p.m. Eastern Time. A simultaneous webcast of the presentation will be accessible from the GTx website at www.gtxinc.com. An archived replay of the presentation will be available on the company website until March 26.
